The molecular mechanisms that activate morphogenesis of cerebral cortex are currently the subject of intensive experimental analysis. Transcription factor genes of the homeobox, basic helix-loophelix (bHLH) and zinc-finger families have recently been shown to have essential roles in this process. However, the actual selector genes activating corticogenesis have not yet been identified. Here we show that high-level expression of at least one functional allele of either of the homeobox genes Emx2 or Pax6 in the dorsal telencephalon is necessary and sufficient to stably activate morphogenesis of cerebral cortex and to repress that of adjacent structures, such as striatum.
morphologically and molecularly distinguishable from adjacent structures such as basal ganglia and fimbria.
We have previously observed that some laminar markers expressed throughout the cortical field are downregulated in Emx2 and Pax6 loss-of-function mutants, respectively, in regions where ventricular expression of Emx2 and Pax6 is more intense. This led us to suggest that Emx2 and Pax6 could independently activate key aspects of the pan-cortical morphogenetic program by acting along parallel pathways and leading neuroblasts in the dorsal telencephalon to adopt cortical fates (ref. 13 and unpub. observ.) . To test this hypothesis, we generated double-knockout mice for Emx2 and Pax6 and analyzed embryonic development of their telencephalon. In these mutants, regionalization of the telencephalic vesicle was dramatically altered. A large set of genes normally restricted to the cortical field were silent, whereas genes normally confined to proliferative layers of the ganglionic field or to the cortical hem were intensely expressed throughout the cortical primordium. This was followed by massive ectopic activation of basal differentiation pathways in the cortical primordium, which finally acquired morphological and molecular features reminiscent of those of the striatum. Robust expression of at least one fully functional allele of either Emx2 or Pax6 therefore seems necessary and sufficient to stably activate corticogenesis and to suppress competing neighboring morphogenetic programs.
staining showed that morphogenesis of cerebral cortex was impaired in Emx2 -/-Pax6 -/-embryos at early stages of cortical development (data not shown). At E14.5, their dorsal telencephalic wall was reduced tangentially and composed of an inner, cell body-rich zone that lined the ventricular cavity, and an outer, fiber-rich plexiform layer (Fig. 1a-c) . By E17.5, this abortive cortical primordium acquired a highly aberrant morphological profile resembling adjacent basal ganglia ( Fig. 1d and e) .
To dissect the molecular regionalization of the developing Emx2 -/-Pax6 -/-telencephalon, we scored mid-neuronogenetic expression patterns of two sets of genes normally confined to the pallial and the subpallial wall. The pallial transcription factor genes Tbr2, Ngn2, Ngn1, Pax6 and Emx1 5, 8, 23, 24 were switched off (Fig. 2d, h , l, p and t), with the exception of a few EMX1-immunoreactive presumptive neurons that were detectable in the marginal cortex (Fig. 2u, arrowheads) . The subpallial markers Gsh2, Vax1, Islet1, Gad65/67, Ebf1, Six3, CRBP-I and Calbindin 4,25-27 were ectopically activated throughout the cortical primordium according to the ventricular-tomarginal progression they exhibit in developing basal ganglia (Fig. 3a, d , e, h, m, p, q, t, u and x and data not shown). Moreover, the transcription factor gene Nkx2.1, normally confined to the medial ganglionic eminence (MGE) 28 , was also ectopically expressed in the lateral ganglionic eminence (LGE; Fig. 3i and l) . These patterns suggest that cortexto-LGE and LGE-to-MGE molecular-specification shifts did occur in Emx2 -/-Pax6 -/-mutants. To test if cortical hem and choroid plexus fates also spread into the pallial field of these mutants, we analyzed the expression of several genes that demarcate boundaries among pallium, hem and choroid plexus. The genes Id3, Otx2 and Msx1, normally restricted to heminested domains including the cortical hem and the choroid plexus 11, 29, 30 , (Fig. 4m , e and i) were expressed in a large part of the dorsal telencephalon (Fig. 4p, h, l and d) , but the choroid plexus marker Ttr1 30 was not (Fig. 4a) , suggesting that cortical hem identities spread into this structure. However, this phenomenon was largely incomplete. Lhx2 and Bf1, normally detectable throughout the telencephalon except for the cortical hem 1,2,31 , were not affected, with the exception of anomalous Bf1 negative patches in the marginal-dorsal pallium ( Fig. 4u and x , asterisk, and data not shown); the cortical Fig. 4q and t) . This molecular profile was specific to knockout mice for both genes; anomalies detectable in mice knockout for either Emx2 or Pax6 were much less pronounced. Cortical markers Tbr2, Ngn2 and Ngn1 were downregulated medially in Emx2 -/-Pax6 +/-mutants (Fig. 2b, f and j, arrowheads) and rostro-laterally in Emx2 +/-Pax6 -/-mutants ( Fig. 2c and g , arrowheads, and data not shown); Pax6 was also rostro-laterally downregulated in the latter mutants (Fig. 2o, arrowhead) . Basal markers were unaffected in the presence of at least one functional Pax6 allele (Fig.  3b , f, j, n, r and v); Gsh2 and Vax1 domains were only moderately enlarged in Emx2 +/-Pax6 -/-embryos ( Fig. 3c and  g ). Notably, this pattern of cortex-tobasal ganglia and cortex-to-cortical hem conversion was specific to mice mutant for Emx2 and Pax6. In double-knockout embryos for Pax6 and the Emx2 paralog, Emx1 19 , Tbr2 and Ngn2 were expressed throughout the archicortical anlage and Otx2 was tightly confined to cortical hem and choroid plexus; moreover, Gsh2 was not differentially expressed in their brains as compared with those of Pax6 -/-embryos (data not shown).
Respecification of Emx2 -/-Pax6 -/-cortical neuroblasts To cast light on mechanisms leading to the large-scale regionalization defects described above, we re-analyzed the molecular profile of Emx2 -/-Pax6 -/-mutants at earlier stages. Defects in cortical specification were evident from the onset of cortical neuronogenesis (E11). Pax6, normally expressed in the dorsal telencephalon in a high-lateral to low-medial gradient (Fig. 5a) , was dramatically downregulated, being detectable in a few cells in the medial cortical field (Fig. 5b, solid arrowheads) ; Emx1 was also downregulated (Fig. 5d, solid arrowheads) ; Tbr2, normally expressed at this age in postmitotic neurons in the marginal zone (MZ) and in proliferating cells clustered in the lateral ventral zone (VZ; Fig. 5e ), was almost undetectable, with its expression confined to rare marginal cells in the medial cortical field (Fig. 5f , solid arrow- heads). This mis-specified cortical primordium was instead ventralized and acquired features of LGE. Laterally, it expressed the LGE-specific homeogene Gsh2 (Fig. 8j) ; pan-basal markers Mash1, Dlx1, Dlx2, Islet1 and Gad65/67 (but not MGE-specific markers Shh 28 and Lhx6 33 ) were activated throughout its medial-lateral extent (Fig. 6d , h and l and data not shown). Finally, we detected no spreading of cortical-hem fates into the cortical field at this stage, as suggested by Wnt3a and Wnt8b expression profiles 32 (data not shown). These findings are in agreement with the more pronounced phenotype that characterizes mid-neuronogenetic stages, when all ventricular cortical markers are switched off and cortical neuroblasts exhibit molecular properties highly similar to those of striatal neuroblasts, suggesting that late morphological abnormalities may arise largely from early patterning defects. escape the striatum and migrate through the cerebral cortex 35 . Almost no Lhx6 + , Lhx7 + or Nrp1 + cells could be detected in the dorsal telencephalic wall of Emx2 Pax6 double knockouts (data not shown), suggesting that ventral interneurons did not flow in an uncontrolled manner into the cortex of these mutants. This interpretation was also confirmed by in vivo short-term 5-bromodeoxyuridine (BrdU) pulse-chase experiments, in which E11.5 wild-type and Emx2 Pax6 doublemutant embryos were pulsed by BrdU and fixed after 8 h, followed by analysis of the distribution of cells immunoreactive for BrdU and the basal ganglia postmitotic marker Islet1. We reasoned that this delay should be long enough to allow newborn neurons to reach the marginal edge of proliferative layers 36 and to switch Islet1 on 28 , and too short for them to subsequently move far in the tangential plane from their place of birth 37, 38 . As expected, numerous BrdU + Islet1 + cells were found in the basal telencephalon of both genotypes (Fig. 7a , e-g and data not shown), but a substantial number of BrdU + Islet1 + cells were also found throughout the medial-lateral extent of the marginal cortical field of Emx2 -/-Pax6 -/-mutants ( Fig. 7a, b-d) . We obtained similar results by comparing distributions of BrdU and GAD on the same embryos (not shown). These findings suggest that a large fraction of Islet1 + and GAD + cells detectable in the pallial telencephalon of Emx2 -/-Pax6 -/-mutants was locally generated.
To determine whether progenitors of these Islet + and GAD + cells were autochthonous or came from basal forebrain, we analyzed the growth kinetics of cortical population using a variety of approaches. In both wild-type and Emx2 -/-Pax6 -/-telencephalons, almost all cells in the ventricular zone expressed the proliferating cell nuclear antigen (PCNA) 39 independently on their dorsoventral location ( Fig. 8b and f) . Mitotic cells immunopositive for phosphohistone H3 (ref. 40) , were found at similar spatial frequencies along the entire ventricular edge of the telencephalic wall, in both wild type and double knockouts ( Fig. 8c and g ). BrdU-uptake profiles, as detected in pulse-chase experiments previously described (Fig. 7a and b and data not shown), did not suggest any marked reduction of proliferation rates in the dorsomedial pallium of double mutants, where a residual cortical specification is still retained at E11 (Fig. 5) . Finally, cells immunopositive for the apoptotic marker activated caspase3 (ref. 41) were very rare in the cortical fields of both c, g, k, o, s, w) and Emx2 -/-Pax6 -/-(d, h, l, p, t, x) E14.5 (a-t) and E12.5 (u-x) embryos. Frontal sections, medial to the right. In (e-t), solid arrowheads point to expression domains in the hem and in the pallial field, asterisks mark choroid plexus domains; in (d) an empty arrowhead indicates presumptive dorsal tele-diencephalic border; in (u-x), arrows demarcate the dorsomedial boundary of the Bf1 expression domain; in (x), asterisk marks a large patch of cortical tissue not expressing Bf1. Scalebar, 200 µm.
Remarkably, large numbers of neurons expressing Islet1, GAD65/67, Calbindin and Ebf1 accumulated in the marginal zone of the cortical field between E11 and E16, giving it a striatumlike molecular profile. To explain this accumulation, we considered three hypotheses. First, interneurons born in the basal telencephalon and migrating to more dorsal locations may have massively penetrated abventricular layers of the dorsal telencephalon, thus diluting the less numerous, locally born neurons of cortical phenotype. Second, after a proliferative collapse and/or a burst of apoptosis in cortical germinative layers, basal neuroblasts may have massively infiltrated these layers and replaced local proliferating populations, subsequently generating neurons of basal phenotype. Third, cortical neuroblasts may have been respecified, that is, homeotically transformed into basal neuroblasts able to generate Islet1 + GAD + neurons.
To assay the first hypothesis, we scored the distribution of three markers expressed by migrating neurons born in the MGE: the LIM homeobox gene Lhx6, expressed by GABAergic neurons, which spread throughout the telencephalon 33 ; the LIM homeobox gene Lhx7, possibly restricted to acetylcholinergic neurons that diffuse into the adjacent striatum 34 ; and the semaphorin receptor Nrp1, expressed by a very large set of interneurons that the primitive telencephalic wall. We show here that if the two homeobox genes Emx2 and Pax6, normally expressed at high levels in the developing cortical primordium, are both inactivated, the telencephalic pallial neuroblasts are re-specified as subpallial neuroblasts, and this is followed by formation of an additional striatum-like structure in place of the cerebral cortex. The analysis of mid-neuronogenetic molecular profiles of Emx2 -/-Pax6 -/-telencephalons suggests that both Emx2 and Pax6 are involved in more than one primary developmental choice. On the dorsomedial side of the dorsal telencephalic wall, it is determined at an early stage whether neuroblasts will give rise to cortical hem or to cortex. The BMP-dependent restriction of Lhx2 to the cortical field is essential for this process 1,2 , molecular correlates of which are the confinement of Bf1 to the cortical field 43 and the activation of Msx1 and Otx2 in the cortical hem 29, 30, 43 . The upregulation of Msx1 and Otx2 and the presence of patches of tissue free of Bf1 expression in the Emx2 -/-Pax6 -/-cortical primordium suggest that Emx2 and Pax6 normally cooperate with Lhx2 in repressing hem-specific programs in the cortical field. At more ventral locations, neuroblasts will generate either cerebral cortex or basal ganglia. Shh-dependent activation of Nkx2.1 and Gsh2 in the anlagen of MGE and LGE promotes pallidal and striatal morphogenetic programs, respectively, and downregulates cortical markers 27, 28, 44, 45 . Low levels of Pax6 mRNA, normally available in the LGE, are sufficient to confine Nkx2.1 to the MGE; in the absence of Pax6, Nkx2.1 is activated in the medial LGE, which acquires features of the MGE 21 .
In a similar way, high levels of Pax6 product, normally avail- genotypes ( Fig. 8d and h) . Thus, no growth collapse occurred in the Emx2 -/-Pax6 -/-cortical VZ, suggesting that cortical neuroblasts of double mutants were not fully replaced by basal neuroblasts and could contribute, upon striatal respecification, to generation of the local neuronal complement. To verify this inference, we scored early dorsal telencephalon for cells coimmunopositive for pallial and subpallial markers, reasoning that these cells would serve as an index of ongoing homeotic respecification. Emx1 and Gsh2, normally restricted to distinct telencephalic progenitors, respectively committed to cortical and ganglionic morphogenetic programs 3 , were co-expressed in the majority of neuroblasts the lateral cortical field of E11.5 Emx2 -/-Pax6 -/-mutants ( Fig. 8i-j 3, 4, 17 , which acquires molecular features of striatum. However, the dorsal shifts of striato-pallidal and cortico-striatal boundaries detectable in Pax6 -/-mice are limited, and the lateral LGE and the dorsomedial pallium retain striatal and cortical specifications, respectively 3, 4, 17, 21 . In this study we found that a more severe phenotype results if Emx2 is knocked out in addition to Pax6. Nkx2.1 reaches the corticostriatal notch, conferring MGE properties to the entire ganglionic eminence (compare Fig. 3u and x) ; this implies that EMX2, expressed at low levels in baso-lateral telencephalon (unpub. data), normally cooperates with PAX6 in patterning this structure. Moreover, the entire dorsal telencephalon, including dorsal and medial pallium, loses the expression of a large set of transcription factor genes normally restricted to the developing cortex (Emx1, Ngn2, Ngn1, Tbr2 and Pax6) and conversely expresses a set of transcription factor genes peculiar to baso-lateral telencephalon (Gsh2, Vax1, Mash1, Dlx1, Dlx2 and Six3) . This is associated with ectopic activation of striatal abventricular markers (Islet1, Calbindin, Gad65/67 and Ebf1) in the cortical intermediate-marginal zone, suggesting that, in the absence of Emx2 and Pax6, the entire cortical primordium converts into striatum. This phenotype was highly specific to Emx2 -/-Pax6 -/-mutants; nothing similar was found in Emx1 -/-Pax6 -/-mutants, in spite of structure and expression similarities between the two Emx paralogs. Moreover, dorsal markers were also downregulated in partial Emx2 Pax6 null mutants, but this was limited to restricted cortical regions. Therefore, high-level expression of either Pax6 or Emx2 in the telencephalic wall is specifically necessary and sufficient to promote corticogenesis and repress morphogenesis of basal ganglia. Indeed, selective downregulation of Tbr2, Ngn1 and Ngn2 in pallial regions of Emx2 -/-Pax6 +/-and Emx2 +/-Pax6 -/-mutants where the fully knocked-out gene normally would be more intensely expressed 9 , strongly supports the hypothesis that Emx2 and Pax6 promote corticogenesis by acting along parallel pathways.
By BrdU administration and subsequent BrdU/Islet and BrdU/GAD colocalization, we have shown that neurons accumulating in marginal layers of the Emx2 -/-Pax6 -/-cortical primordium were presumably locally born. Pallial absence of interneuron markers, such as Lhx6, Lhx7 and Nrp1, and pallial activation of genes normally restricted to resident populations of basal ganglia, such as Islet1 and Ebf1, further support this interpretation. However, to prove that Emx2 and Pax6 act as proper selector genes for corticogenesis, it is crucial to assess that progenitors generating subpallial neurons in the 'cortex' of Emx2 -/-Pax6 -/-embryos were, at least partially, respecified pallial neuroblasts. First, in the absence of Emx2 and Pax6, cortical proliferating populations could collapse; second, Emx2 -/-Pax6 -/-mutants, like simple Pax6 -/-knockouts, could lack the functional barrier which normally inhibits migration of basal blasts into the cortical VZ [46] [47] [48] . These events would result in rapid and full replacement of cortical neuroblasts by dorsally migrating basal neuroblasts, and no proper respecification would occur. However, distributions of PCNA, phosphohistone H3, BrdU and activated caspase3 indicate that dorsal neuroblasts retaining residual cortical specification at E11.5 were somehow healthy and actively proliferating. Moreover, many of these cells abnormally co-expressed Emx1 and Gsh2, or Emx1, Dlx1 and Mash1; this suggests they were undergoing cortical-to-basal respecification, making them able to contribute to generation of the striatum-like structure, detectable in brains of late gestation Emx2 -/-Pax6 -/-embryos, in place of cerebral cortex (Figs. 1e and 3x) .
Emx2, Pax6 and dorsoventral telencephalic patterning
Activation of basal ganglia markers in the cortical anlage is not peculiar to Emx2 Pax6 mutants, but takes place also in other mutants.
Cortical upregulation of Gad67 and Dlx1 occurs upon cortical overexpression of the subcortical proneural gene Mash1 and/or inactivation of cortical proneural genes Ngn1 and Ngn2. However, other basal ganglia markers, such as Islet1, are not ectopically induced by Mash1; moreover, whereas Mash1 and Ngn2/1 expression patterns are deeply perturbed in Emx2 Pax6 double knockouts (Figs. 2 and 6) , neither overexpression of Mash1 nor ablation of Ngn2 impair expression of Emx1, Emx2 and Pax6 in cortical neuroblasts; more generally, neither of these genetic manipulations lead to dramatic changes in gross morphology and cytoarchitecture, characterizing the cortex of Emx2 -/-Pax6 -/-mutants 5 . This suggests that Emx2 and Pax6, as general activators of corticogenesis, act at a higher hierarchical level as compared to Ngn1 and Ngn2, which, moreover, would master execution of more limited aspects of cortical morphogenetic programs. Similar considerations might apply to Nkx2.1, Gsh2 and Mash1, respectively, in development of basal ganglia.
Cortical upregulation of Dlx2 and downregulation of Emx1 also occur in mice naturally mutant for the zinc finger gene Gli3. Here, however, ventral master genes, such as Nkx2.1, do not spread to more lateral locations; moreover Emx2, Pax6 and Ngn2 are still expressed in the dorsal telencephalon, even if at lower levels 6, 7 . This suggests that Gli3 does not properly act as selector of cortical fates, but rather promotes cortical morphogenetic pathways, by positively modulating expression of Emx2 and Pax6.
Finally, even in the Emx2 -/-Pax6 -/-cortical primordium, corticostriatal respecification is not complete around E11, when substantial amounts of Emx1 can still be found in the dorsomedial cortical field. The presence of rare Pax6 + neuroblasts and rare Tbr2 + presumptive neurons as well as the almost complete absence of Gsh2 in this area (Figs. 5 and 8 ) led us to suggest that, in the absence of Emx2 and Pax6, Emx1 could initially promote corticogenesis versus morphogenesis of basal ganglia, subsequently failing to sustain the former process because of the requirement of either Emx2 or Pax6 for late maintenance of its expression in the cortical VZ. However, simultaneous inactivation of all three genes, Emx1, Emx2 and Pax6, neither abolished early expression of Tbr2 nor led to early activation of Gsh2 in this area (data not shown). This did not allow us to verify the former hypothesis and conversely suggested that at least another gene, different from Emx1, Emx2 and Pax6, should be able to transiently and independently activate corticogenesis. Lhx2, expressed at high levels in dorsal telencephalon, even in the absence of Emx2 or Pax6, seems to be a reasonable candidate. Further stringent genetic analysis will be needed to test this prediction. 19 , the last ones provided by S. Aizawa. Pax6 -/-embryos were recognized by the absence of eyes, Pax6 +/-embryos by ocular abnormalities; Pax6 genotypes were confirmed by direct sequencing of genomic DNA 22 . Emx2 mutant embryos were genotyped by PCR [oligos: E2F, 5′ CAC AAG TCC CGA GAG TTT CCT TTT GCA CAA CG 3', E2R/WT, 5′ ACC TGA GTT TCC GTA AGA CTG AGA CTG TGA GC 3', E2R/KO, 5′ ACT TCC TGA CTA GGG GAG GAG TAG AAG GTG G 3'; program: 98°C/5' (1X), 98°C/1' -72°C/2' (5X), 94°C/1' -72°C/2' (30X), 72°C/10' (1X); PCR products: 180bp (wt allele), 340bp (null allele)] and genotypes were confirmed by Southern when appropriate 18 . Emx1 mutant embryos were genotyped by PCR [oligos: E1F, 5′ CGA CGT TCC CCA GGA CGG GCT GCT TTT GC 3', E1R/WT, 5′ GTC TCG GAG AGG CTG AGG CTG CCT GCC AGC 3', NR/KO, 5′ ACT TCC TGA CTA GGG GAG GAG TAG AAG GTG G 3'; program: 98°C/5' (1X), 98°C/1' -72°C/2' (5X), 94°C/1' -72°C/2' (30X), 72°C/10' (1X); PCR products: 180bp (wt allele), 230bp (null allele)] and genotypes were confirmed by Southern when appropriate 19 .
METHODS
Pregnant females were anasthetized by CO 2 and killed by cervical dislocation, in compliance with European laws (European Communities Council Directive of November 24, 1986 (86/609/EEC)) and according to guidelines of H San Raffaele Institutional Animal Care and Use Committee (HSR-IACUC). Embryos were fixed in 4% paraformaldehyde-PBS overnight at 4°C and then washed, dehydrated, and embedded in wax according to standard protocols. Embryonic brains were cut at 10 mm and sections were mounted on Fischer SuperFrost Plus slides. Samples were subsequently dewaxed by xylene, rehydrated in descending ethanol series, and processed for in situ hybridization or immunohistochemistry. Alternatively, embryonic brains, upon 4% paraformaldehyde-PBS fixation, were cryoprotected by 30% sucrose-1X PBS, included in OCT and cut at 10 µm by cryostat. Cryosections, mounted on Fischer SuperFrost Plus slides, were used as such.
Immunohistochemistry-immunofluorescence. Antigens were generally unmasked by boiling samples in 10 mM sodium citrate, pH 6.0, for 5 min and allowing them to cool down slowly, prior to applying conventional immunohistochemistry-immunofluorescence protocols. In the case of BrdU detection, to depurinate genomic DNA and make the epitopes accessible, slides were kept in 2 M HCl for 30 min at 60°C and then neutralized in 0.1 M borate buffer, pH 8.5, for 15 min at RT. Immunohistochemistries were performed according to ref. 9; for immunofluoresences, Alexa secondary antibodies (Molecular Probes, Eugene, Oregon) were used, according to Manifacturer's instructions. When double immunos were performed with two primary antibodies raised in the same species, the two tests were performed sequentially and, just before the second immuno, the first primary antibody was masked by a large excess of unconjugated secondary antibody; in this case, specific negative controls were run as appropriate. The following primary antibodies were used: anti-BrdU, mouse monoclonal (Becton-Dickinson, San Josè, California), 1:75; anti-(activated) caspase3, rabbit monoclonal (BC PharMingen, San Diego, California), 1:300; anti-Emx1, rabbit polyclonal , gift of G.Corte) 1:500; anti-GABA, rabbit polyclonal (Sigma, Saint Louis, Missouri), 1:300; anti-GAD65/67, rabbit polyclonal (Chemicon, Temecula, California), 1:250; anti-GAD65/67, rabbit polyclonal (Sigma), 1:1600; anti-Gsh2, rabbit polyclonal (gift of K. Campbell), 1:2000; anti-phosphohistone H3, rabbit polyclonal (Upstate Biotechnology, Lake Placid, New York), 1:600; anti-Islet1, mouse monoclonal (gift of P. Bovolenta), 1:500; anti-MAP2, mouse monoclonal (Roche, Indianapolis, Indiana,), 1:100; antineurospecific classIII β-tubulin, mouse monoclonal (BabCo, Richmond, California), 1:500; anti-Otx2, rabbit polyclonal 49 In the version of this article initially published, author Barbara Di Benedetto's name was misspelled. The error has been corrected in the HTML and PDF versions of the article.
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